MESALAZOL suppositories

Composition:
Each suppository contains: mesalazine 250 mg or 500 mg, as active substance.

Therapeutic indication:
Used for treatment of inflammatory lesions (inflammatory bowel disease) of the rectum and distal colon.

Pharmacotherapeutic group and ATC code:
Intestinal antiinflammatory agents. Mesalazine. A07EC02.